Bristol Myers Squibb is committing $300 million to fighting racial health disparities.The drugmaker also plans to diversify clinical trials and its workforce. This is the largest commitment made by a drugmaker so far to combat racial inequality. (Endpoints)

Russia’s coronavirus vaccine will be ready for use in November. The country claimed it has been developing the vaccine for over six years while working on Ebola and MERS vaccines. (CNBC)

The U.S. government will buy 100 million doses of Moderna’s coronavirus vaccine. The drugmaker is also giving the government the option to purchase 400 million more doses. (CNBC)

Could antibody drugs help treat or prevent COVID-19? In the case that a coronavirus vaccine isn’t readily accessible or isn’t as effective as hoped, some believe antibody treatments are the next best option. (AP News)

SK Life Science’s Sebby Borriello joins Larry Dobrow on this week’s episode of The MM&M Podcast. Borriello details his company’s experience launching Xcopri, an epilepsy drug, during the COVID-19 crisis. (MM&M)